Literature DB >> 22568387

Rendering protein-based particles transiently insoluble for therapeutic applications.

Jing Xu1, Jin Wang, J Christopher Luft, Shaomin Tian, Gary Owens, Ashish A Pandya, Peter Berglund, Patrick Pohlhaus, Benjamin W Maynor, Jonathan Smith, Bolyn Hubby, Mary E Napier, Joseph M DeSimone.   

Abstract

Herein, we report the fabrication of protein (bovine serum albumin, BSA) particles which were rendered transiently insoluble using a novel, reductively labile disulfide-based cross-linker. After being cross-linked, the protein particles retain their integrity in aqueous solution and dissolve preferentially under a reducing environment. Our data demonstrates that cleavage of the cross-linker leaves no chemical residue on the reactive amino group. Delivery of a self-replicating RNA was achieved via the transiently insoluble PRINT protein particles. These protein particles can provide new opportunities for drug and gene delivery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22568387      PMCID: PMC3365610          DOI: 10.1021/ja302363r

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  20 in total

1.  The effect of particle design on cellular internalization pathways.

Authors:  Stephanie E A Gratton; Patricia A Ropp; Patrick D Pohlhaus; J Christopher Luft; Victoria J Madden; Mary E Napier; Joseph M DeSimone
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

2.  Modifications of therapeutic proteins: challenges and prospects.

Authors:  Nigel Jenkins
Journal:  Cytotechnology       Date:  2007-05-25       Impact factor: 2.058

3.  Shape-specific, monodisperse nano-molding of protein particles.

Authors:  Jennifer Y Kelly; Joseph M DeSimone
Journal:  J Am Chem Soc       Date:  2008-04-01       Impact factor: 15.419

4.  A novel intracellular protein delivery platform based on single-protein nanocapsules.

Authors:  Ming Yan; Juanjuan Du; Zhen Gu; Min Liang; Yufang Hu; Wenjun Zhang; Saul Priceman; Lily Wu; Z Hong Zhou; Zheng Liu; Tatiana Segura; Yi Tang; Yunfeng Lu
Journal:  Nat Nanotechnol       Date:  2009-11-22       Impact factor: 39.213

5.  Reversible pH lability of cross-linked vault nanocapsules.

Authors:  Marcella Yu; Benny C Ng; Leonard H Rome; Sarah H Tolbert; Harold G Monbouquette
Journal:  Nano Lett       Date:  2008-09-20       Impact factor: 11.189

6.  Human serum albumin-polyethylenimine nanoparticles for gene delivery.

Authors:  Stephanie Rhaese; Hagen von Briesen; Helga Rübsamen-Waigmann; Jörg Kreuter; Klaus Langer
Journal:  J Control Release       Date:  2003-09-19       Impact factor: 9.776

7.  The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies.

Authors:  Jin Wang; Shaomin Tian; Robby A Petros; Mary E Napier; Joseph M Desimone
Journal:  J Am Chem Soc       Date:  2010-08-18       Impact factor: 15.419

Review 8.  Protein nanoparticles as drug carriers in clinical medicine.

Authors:  Michael J Hawkins; Patrick Soon-Shiong; Neil Desai
Journal:  Adv Drug Deliv Rev       Date:  2008-02-07       Impact factor: 15.470

9.  Free sulfhydryl in recombinant monoclonal antibodies.

Authors:  Wei Zhang; Marta J Czupryn
Journal:  Biotechnol Prog       Date:  2002 May-Jun

10.  Fluorescence imaging of cellular glutathione using a latent rhodamine.

Authors:  Marcos M Pires; Jean Chmielewski
Journal:  Org Lett       Date:  2008-02-08       Impact factor: 6.005

View more
  17 in total

1.  Engineered PRINT(®) nanoparticles for controlled delivery of antigens and immunostimulants.

Authors:  Anton Beletskii; Ashley Galloway; Shyam Rele; Michele Stone; Frank Malinoski
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Shape Control in Engineering of Polymeric Nanoparticles for Therapeutic Delivery.

Authors:  John-Michael Williford; Jose Luis Santos; Rishab Shyam; Hai-Quan Mao
Journal:  Biomater Sci       Date:  2015-07       Impact factor: 6.843

3.  Conjugation Chemistry-Dependent T-Cell Activation with Spherical Nucleic Acids.

Authors:  Kacper Skakuj; Shuya Wang; Lei Qin; Andrew Lee; Bin Zhang; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2018-01-22       Impact factor: 15.419

Review 4.  Physical stability of dry powder inhaler formulations.

Authors:  Nivedita Shetty; David Cipolla; Heejun Park; Qi Tony Zhou
Journal:  Expert Opin Drug Deliv       Date:  2019-12-13       Impact factor: 6.648

5.  Formulation of High-Performance Dry Powder Aerosols for Pulmonary Protein Delivery.

Authors:  Erin M Wilson; J Christopher Luft; Joseph M DeSimone
Journal:  Pharm Res       Date:  2018-08-23       Impact factor: 4.200

6.  Reductively Responsive Hydrogel Nanoparticles with Uniform Size, Shape, and Tunable Composition for Systemic siRNA Delivery in Vivo.

Authors:  Da Ma; Shaomin Tian; Jeremy Baryza; J Christopher Luft; Joseph M DeSimone
Journal:  Mol Pharm       Date:  2015-09-04       Impact factor: 4.939

Review 7.  Future of the particle replication in nonwetting templates (PRINT) technology.

Authors:  Jing Xu; Dominica H C Wong; James D Byrne; Kai Chen; Charles Bowerman; Joseph M DeSimone
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-13       Impact factor: 15.336

8.  Generating Better Medicines for Cancer.

Authors:  Stuart S Dunn; James D Byrne; Jillian L Perry; Kai Chen; Joseph M Desimone
Journal:  ACS Macro Lett       Date:  2013-04-24       Impact factor: 6.903

9.  RNA replicon delivery via lipid-complexed PRINT protein particles.

Authors:  Jing Xu; J Christopher Luft; Xianwen Yi; Shaomin Tian; Gary Owens; Jin Wang; Ashley Johnson; Peter Berglund; Jonathan Smith; Mary E Napier; Joseph M DeSimone
Journal:  Mol Pharm       Date:  2013-08-21       Impact factor: 4.939

10.  Precisely tunable engineering of sub-30 nm monodisperse oligonucleotide nanoparticles.

Authors:  Antons Sizovs; Xianzhou Song; M Neal Waxham; Yilong Jia; Fude Feng; Jianwei Chen; Amanda C Wicker; Jianming Xu; Yan Yu; Jin Wang
Journal:  J Am Chem Soc       Date:  2013-12-17       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.